Avenue Therapeutics, Inc. · OTC:ATXI
Ikarian Capital, LLC reported a 6.80% stake in Avenue Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Ikarian Capital, LLC reported a 6.80% stake in Avenue Therapeutics, Inc., 140,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 6.80%
- Shares
- 140,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 6.80% | 140,000 |
| Neil Shahrestani | 6.80% | 140,000 |
Source
Related
- Avenue Therapeutics, Inc.
- Ikarian Capital, LLC
- Avenue Therapeutics, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Feb 17, 2026
- Schedule 13D/A · Fortress Biotech, Inc. · Jan 6, 2026
- Schedule 13D/A · Fortress Biotech, Inc. · Apr 2, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Schedule 13D/A · Fortress Biotech, Inc. · Jan 3, 2025